Who is sponsoring NCT03699436?

NCT03699436 is sponsored by Universidad de Granada.

What drugs are being tested in NCT03699436?

Interventions in NCT03699436: Electrotherapy with Galvanic Current, Control without Electric Stimulation Therapy.

What condition does NCT03699436 study?

NCT03699436 studies Raynaud Phenomenon, Raynaud Disease.

Is NCT03699436 still recruiting?

NCT03699436 is currently completed. Last updated 9 November 2020.

Last reviewed 2020-11-09 · How we verify

NCT03699436

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon

Completed NA Last updated 9 November 2020

What this trial tests

NA trial testing Electrotherapy with Galvanic Current in Raynaud Phenomenon in 60 participants. Completed in 20 February 2019.

Timeline

1 October 2018

Primary endpoint
1 December 2018

20 February 2019

Quick facts

Lead sponsor	Universidad de Granada
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	1 October 2018
Primary completion	1 December 2018
Estimated completion	20 February 2019
Sites	1 location across Spain

Drugs / interventions tested

Electrotherapy with Galvanic Current
Control without Electric Stimulation Therapy

Conditions studied

Raynaud Phenomenon — all drugs for Raynaud Phenomenon →
Raynaud Disease — all drugs for Raynaud Disease →

Sponsor

Universidad de Granada — full company profile →

Who can join

18 and older, any sex, with Raynaud Phenomenon or Raynaud Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to analyze the effects of an intervention with galvanic electrical current on the number of attacks , temperature, pain, peripheral blow flow and upper limb functionality in patients with Raynaud's Phenomenon in comparison to a control group that will maintain their habitual treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Management of Raynaud's phenomenon in systemic sclerosis-a practical approach.
Fernández-Codina A, Cañas-Ruano E, Pope JE, Pope JE. · · 2019 · cited 15× · PMID 35382396 · DOI 10.1177/2397198318823951

Verify or expand the search:

Other Universidad de Granada trials

Trials by the same sponsor.

NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
NCT07528924 — TuJugling: Comparing Two Juggling Learning Methods in College Students · NA · recruiting
NCT07388134 — Virtual Reality Based High-intensity Interval Training in Chronic Low Back Pain · NA · active not recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT06518200 — Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03699436 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Granada
Last refreshed: 9 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03699436.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing